The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
CISA CIO on Agentic AI, Building the Cyber Workforce
Bob Costello discusses deploying agentic AI, speeding cyber approvals and strengthening the federal cybersecurity talent pipeline.
9m watch -
A New Era of Open-Source Geospatial Collaboration
Former NGA official Will Mortenson shares his journey from 27 years of government service to leading a global mapping revolution at the Overture Maps Foundation.
7m watch -
AI Demands Secure, Expanded Data Infrastructure
Growing AI workloads are forcing agencies to rethink storage, cybersecurity and infrastructure investments to support innovation.
5m watch -
Flipping the Script on AI Adoption at Space Force
The newest military service is moving away from off-the-shelf solutions to build a culture of internal innovation and mission-specific tools.
10m watch
